P53 gene mutations in non-Hodgkin’s lymphoma

Abstract

To understand P53 gene change of non-Hodgkin’s lymphoma (NHL) and human malignant lymphoma cell lines, the exons 5–7 of 29 patients with NHL and 9 kinds of human malignant lymphoma cell lines were studied by silver staining PCR-SSCP technique. Three cases of P53 gene point mutation was found in 29 cases of NHL. Mutation developed in exon 5 in 2 cases, and in exon 6 in 1 case. They were all diffuse lymphoma. In mutation cases, B-cell lymphoma accounted for 2 cases and the other one was T-cell lymphoma. There was no P53 gene mutation in low-grade follicular lymphoma. Seven strains out of 9 kinds of lymphoma cell lines had P53 gene point mutation. One strain had the mutation in exon 5; 5 strains in exon 6 and 1 strain in exons 5, 6, 7. There was a high mutation rate in lymphoma cell lines and low mutation rate in NHL patients. P53 gene plays an important role in lymphoma cell line establishment, cell regeneration and disease evolution.

Keywords

non-Hodgkin’s lymphoma / P53 gene mutation

References

[1] P53 1995, 3:141

[2] 61 P53, 1997, 10:166

[3] UppenkampM. Southern 9, 1996, 25(3): 225

[4] PreudhommeC, FenauxP. The clinical significance of mutations of the P53 tumor suppressor gene in haematological malignancies. Bri J Haematol, 1997, 98: 502-502

[5] GaidanoG, BalleriniP, GongJ Z, et al. . P53 mutation in human lymophoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA, 1991, 88: 5413-5413

[6] IchikawaA, HottaT, TakaqiN, et al. . Mutations of P53 gene and their relation to disease progression in B-cell lymphoma. Blood, 1992, 79: 2791-2791